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DRP (p < 0.05). All those regulations are dose dependent and
time dependent.
Conclusions: The FM1 induce the TLR7 signal Transduction
passageway and serial reactions in it. One of the Mechanism
of DRP curing the Inﬂuenza Virus FM1 is effecting on NF-úB
through inhibiting MyD88 in order to regulate the target
gene expression downstream in that signal passageway.
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Israel
The clinical spectrum of chronic or recurrent manifestations
of CNS and PNS diseases suspected to be related to the
group of Herpes Viruses has been expanded considerably
during the last hundred years since J. Ramsay Hunt ﬁrst
deﬁned in 1907 a syndrome of Zoster Oticus accompanied
by peripheral facial nerve paralysis which bears his name,
Ramsay Hunt Syndrome [RHS], and suggested its association
with Varicella zoster virus reactivation.
In this paper the long term [up to 30 years] clinical evolution
of severe, incapacitating attacks of a complex of neurologic
symptoms in two adult women will be presented together
with its diagnostic dilemmas.
These patients were seen by various specialists and
were subjected to numerous diagnostic procedures to
investigate and verify various presumptive non infectious
CNS, orthopedic or ENT disorders. Variable therapeutic
approaches have failed to alleviate their symptoms. Invasive
therapeutic procedures offered to the patients were refused
by them.
Based on meticulous clinical history and physical
examination, the possibility of recurrent reactivations
of VZV in these patients was contemplated (bearing in
mind the less frequent presentations of RHS), and the
patients were put on full dose courses of Acyclovir (Zovirax
or Valtrex). A dramatic and almost immediate clinical
subjective relief and obvious disappearance of symptoms
ensued. Maintenance on a daily-based low dose Acyclovir for
the following months prevented any further exacerbations
and the patients regain full activity and quality of life.
The contribution of new virological diagnostic techniques
in general, and PCR, in particular, to the identiﬁcation and
understanding of variable chronic and recurrent CNS and
PNS diseases and disorders in general, and VZV involvement
in particular, is discussed.
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Background and Aim: Cytomegalovirus (CMV) causes
infection in immunocompromised, transplant recipients
and those who receive blood transfusion frequently. Risk
factors for primary CMV infection are blood transfusion
(including clotting factors, etc), recipients of infected
transplants, hemodialysis and the frequency of dialysis in
a week. This study aimed to determine the prevalence of
cytomegalovirus (CMV) antibodies in end-stage renal disease
(ESRD) patients which undergo hemodialysis.
Material and Methods: This study has a cross-sectional
design, which is executed in 2007 among hemodialysis
patients in Urmia, Iran. Sera of 84 Hemodialysis patients
have been investigated by CMV-speciﬁc immunoglobulin G
(IgG) using a CMV IgG enzyme-labeled antigen test.
Collected data were analyzed by descriptive statistics and
chi-square test via SPSS software ver11.5.
Results: In our study, 84 patients who regularly underwent
hemodialysis were studied. Forty-four patients were male
and 40 female with the range 23 82 years age. In the
time of evaluation, 65 patients (77.4%) were anti-CMV IgG
positive and 6 (7.1%) were anti-CMV IgM positive. There
was no relationship between the antibody titer and dialysis
duration, or frequency of HD in a week.
Conclusion: We recommend that every patient who has
undergone hemodialysis received blood products free of
CMV. Development of a vaccine against cytomegalovirus is
essential and could be very life & cost-saving.
PP-066 Survey of the seroprovalence of HTLV I/II in
hemodialysis patients and blood donors in
Urmia
Z. Rostam, Z.R. Khameneh*, M. Baradaran, N. Sepehrvand.
Urmia University Medical Science, Iran
Introduction: HTLV is a virus from retroviridae family.
It is a cause of Lukemia/Lymphoma disease in adults,
Tropical spastic paralysis, HTLV associated myelopathy,
spastic paraparesis, (HAM/TSP) and some nervous system
disease and etc. It is transmitted by means of blood products
via blood transfusion to recipients.
Material and Methods: This study has a cross-sectional
design, which is executed from April of 2005 until
January of 2006 among healthy blood donors and in 2006
among hemodialysis patients in Urmia, Iran. The serum of
2046 blood donors and 95 Hemodialysis patients has been
investigated by enzyme-linked immunosorbent assay (ELISA)
for anti HTLV-I/II and positive cases has been conﬁrmed by
western blot.
Results: There were 1910 male persons (93.4%) among
2046 donors, and 136 cases (6.6%) were female. Serum
of 1997 cases (97.6%) was negative, and 49 cases (2.6%)
were positive as a result of ELISA tests. Positive cases were
investigated by western blot and 37 cases (75.5%) were
negative, 5 persons (10.2%) were IND and 7 persons (14.3%)
were HTLV positive. Among these seven persons, there are
6 cases (85.6%) with HTLV-I, and only one person (14.3%)
with HTLV-I/II infection. Total serologic prevalence of HTLV
in healthy blood donors is 0.34%.
Conclusion: Observation of such a high serologic prevalence
in the population of blood donors in Urmia city,
suggesting the high probability of transmission through blood
transfusion, and so screening of blood donors for human
T-lymphocyte virus is essential and has suggested.
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Background: Even though millions of lives are saved by
blood transfusion, unsafe transfusion is also putting millions
of people at risk of Transfusion Transmissible Infections
(TTI).
Objective: To measure the magnitude of TTIs and related
risk factors among blood donors.
Setting: Ethiopian Red Cross Blood Bank at the Gondar
University Hospital in Northwest Ethiopia.
Methods: Cross-sectional study among volunteer blood
donors at the Red Cross Blood Bank in Gondar University
Hospital.
Results: Consecutive 600 adult voluntary donors from April
to July 2004 were included. Their mean age was 28± 10.4
years, and 66% were urban dwellers. Donors were farmers
